IP Library Granted Patent US 10,640,809
Granted Patent B2
US 10,640,809 · App. 15/576,382 · Granted May 5, 2020

Methods of analyzing nucleic acids

Inventors: Scott Kuersten (Madison, WI); Agnes Radek (Madison, WI); Ramesh Vaidyanathan (Madison, WI); Haiying Li Grunenwald (Madison, WI)
Assignee: EPICENTRE TECHNOLOGIES CORPORATION
C12Q1/6806C12N15/1096C12Q1/6874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,640,809
App. No.
15/576,382
Granted
May 5, 2020
Kind
B2
Abstract

Presented herein are methods and compositions for analyzing rare nucleic acid species. Some methods presented herein use DNA reassociation kinetics following thermal denaturation to define populations of nucleic acid sequences, e.g., highly abundant (e.g., cDNA from rRNA), moderately abundant, and less abundant or rare sequences (e.g., cDNA from mRNA).

Claims (24)

1. A method of analyzing rare nucleic acid species comprising:

(a) providing a library of double-stranded nucleic acids;

(b) denaturing the library;

(c) renaturing the library under conditions sufficient to renature abundant nucleic acid species, wherein a portion of the library comprising less abundant nucleic acid species does not renature;

(d) contacting the library with a transposase that preferentially binds to double-stranded nucleic acids; and

(e) separating renatured abundant nucleic acid species from the less abundant nucleic acid species.

2. The method of claim 1 , wherein separating comprises immobilizing the transposase to a solid support.

3. The method of claim 1 , wherein the transposase comprises Tn5 or TS-Tn5 transposase.

4. The method of claim 1 , wherein the transposase comprises adaptor sequences which comprise a binding moiety capable of binding to a solid support.

5. The method of claim 4 , wherein the binding moiety comprises biotin and the solid support comprises streptavidin.

6. The method of claim 1 , wherein the transposase comprises adaptor sequences which are not compatible with downstream amplification and sequencing.

7. The method of claim 1 , wherein denaturing comprises heat denaturing.

8. The method of claim 1 , wherein renaturing comprises lowering the denaturation temperature to a temperature of about 40° C. to about 65° C. for a sufficient period of time to renature abundant nucleic acid species.

9. The method of claim 1 , wherein denaturing comprises chemical denaturing.

10. The method of claim 1 , further comprising sequencing the separated less abundant nucleic acid species.

11. The method of claim 1 , wherein the library comprises genomic DNA.

12. The method of claim 1 , wherein the library comprises randomly sheared DNA.

13. The method of claim 1 , wherein the library comprises double-stranded cDNA.

14. The method of claim 1 , wherein the nucleic acids in the library comprise adaptor sequences ligated to the ends of the nucleic acids.

15. The method of claim 14 , wherein the adaptor sequences comprise one or more of: amplification priming binding region, sequencing primer binding region, and promotor sequences for in vitro transcription.

16. The method of claim 1 , wherein the abundant nucleic acid species comprise highly repetitive sequences.

17. The method of claim 1 , wherein the library comprises nucleic acid from a single cell or a small group of cells.

18. The method of claim 1 , wherein the abundant nucleic acid species comprise host sequences and the less abundant nucleic acid species comprise pathogen content.

19. The method of claim 1 , wherein the library comprises genomic RNA.

Assignments (2)
MERGER Recorded Dec 3, 2020
From: EPICENTRE TECHNOLOGIES CORPORATION
To: ILLUMINA, INC.
Reel/Frame 054585/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2018
From: KUERSTEN, SCOTT; RADEK, AGNES; VAIDYANATHAN, RAMESH; GRUNEWALD, HAIYING LI
To: EPICENTRE TECHNOLOGIES CORPORATION
Reel/Frame 047643/0399 →
Continuity (2)
Provisional Application 62168281 · May 29, 2015
Related Publication 20180148767A1 · May 31, 2018